Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-16 Conversion | 2024-09-17 8:13 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 39,876,501 | $0 | 653,787 (Indirect) | View |
Ownership | 2024-09-12 7:14 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 0 | $0 | 3,062,215 (Indirect) | View |
| 2024-05-18 Equity Swap | 2024-05-20 7:47 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 2,680,496 | $0 | 0 (Indirect) | View |
| 2024-02-14 Equity Swap | 2024-02-14 4:02 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 17,713,600 | $0 | 0 (Indirect) | View |
| 2024-01-11 Exercise | 2024-01-16 4:39 pm | 2019-01-18 2024-01-18 | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 145,251 | $0 | 2,680,496 (Indirect) | View |
| 2024-01-11 Exercise | 2024-01-16 4:39 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 145,251 | $12.74 | 2,680,496 (Indirect) | View |
| 2023-12-18 Exercise | 2023-12-20 6:28 pm | N/A N/A | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 1,724 | $38 | 1,702,237 (Direct) | View |
| 2023-12-18 Exercise | 2023-12-20 6:28 pm | N/A 2031-10-03 | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 1,724 | $0 | 1,702,237 (Direct) | View |
| 2023-08-04 Option Award(A) | 2023-09-21 5:02 pm | N/A N/A | Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 506,313 | $0 | 8,281,735 (Indirect) | View |
| 2023-08-04 Option Award | 2023-09-14 9:22 pm | N/A N/A | Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 506,313 | $0 | 8,281,735 (Indirect) | View |
| 2023-05-17 Exercise | 2023-05-19 4:19 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 2,125 | $4.28 | 8,951,463 (Indirect) | View |
| 2023-05-17 Exercise | 2023-05-19 4:19 pm | N/A 2032-06-01 | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 2,125 | $0 | 8,951,463 (Indirect) | View |
| 2023-02-23 Option Award | 2023-02-27 8:30 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 7,899,572 | $0 | 288,114 (Indirect) | View |
| 2023-02-17 Option Award | 2023-02-23 2:16 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 550,000 | $0 | 4,593,629 (Indirect) | View |